CIK 0001789769
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Instil Bio, Inc.
Sign in to watch- Ticker
- TIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 832072195
- Phone
- +1 972-499-3350
- Business address
- 3963 MAPLE AVENUE, SUITE 350, DALLAS, TX, 75219
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-25 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +105,157 | 105,157 | ||
| 2024-09-18 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-02-10 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2023-01-08 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2022-03-04 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2022-03-04 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +750,000 | $8.62 | $6.5M | 750,000 |
| 2021-05-11 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion | +30,000,000 | 30,000,000 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion | +6,098,799 | 36,098,799 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion | +1,431,274 | 37,530,073 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Purchase | +450,000 | $20.00 | $9.0M | 37,980,073 |
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion · Series A Preferred Stock | −25,000,000 | 0 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion · Series B Preferred Stock | −5,082,333 | 0 | ||
| 2021-03-23 | Crouch Bronson CEO and Chairman | Conversion · Series C Preferred Stock | −1,192,729 | 0 | ||
| 2021-03-18 | Crouch Bronson CEO and Chairman | Grant or award · Employee Stock Option (right to buy) | +1,200,000 | 1,200,000 |
Page 1 of 1 · 15 trades